Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Malignant peripheral nerve sheath tumor development during MEK inhibitor treatment: A pre-clinical study and a clinical case series.
Journal: Neuro-oncology advances
Published: April 27, 2026
Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.
Journal: bioRxiv : the preprint server for biology
Published: November 26, 2025
Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults.
Journal: Journal of the National Cancer Institute
Published: May 29, 2025
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 29, 2022
Neopetrothiazide: An Intriguing Pentacyclic Thiazide Alkaloid from the Sponge Neopetrosia sp.
Journal: Organic letters
Published: April 13, 2021
Denigrins and Dactylpyrroles, Arylpyrrole Alkaloids from a Dactylia sp. Marine Sponge.
Journal: Journal of natural products
Published: November 05, 2020
Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
Journal: Skeletal muscle
Published: November 19, 2018
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastoma.
Journal: Oncotarget
Published: May 27, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026